Belite Bio Inc (BLTE)
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
Best Photography Camera Models for Professionals in 2026
Best Office Headphones for Professional Environments in 2026
Best Nutribullet Blender Models for Efficient Nutrition Extraction in 2026
Best Office Printers for Small to Medium Businesses in 2026
Best Nikon Camera Models for Photography Enthusiasts in 2026
REGENCELL BIOSCIENCE HOLDINGS LIMITED FILED ITS ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR ENDED JUNE 30, 2025
Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
INOVIO Reports Inducement Grant Under Inducement Plan